Redcare Pharmacy NV

RDC

NL0012044747

Drug Retailers

Real-time Estimate Tradegate Other stock markets 09:53:20 2024-05-07 am EDT			5-day change	1st Jan Change
133.7 ^EUR	+1.83%		+5.20%	+1.52%

Apr. 26	REDCARE PHARMACY : Deutsche Bank reiterates its Buy rating	ZD
Apr. 26	REDCARE PHARMACY : Hauck & Aufhauser keeps its Buy rating	ZD

REDCARE PHARMACY : Warburg Research reaffirms its Neutral rating

April 25, 2024 at 07:49 am EDT

Analyst Michael Heider from Warburg Research research gives the stock a Neutral rating. The target price is unchanged and still at EUR 138.

Latest news about Redcare Pharmacy NV

REDCARE PHARMACY : Deutsche Bank reiterates its Buy rating	Apr. 26	ZD
REDCARE PHARMACY : Hauck & Aufhauser keeps its Buy rating	Apr. 26	ZD
REDCARE PHARMACY : Receives a Buy rating from Baader Bank	Apr. 25	ZD
REDCARE PHARMACY : Warburg Research reaffirms its Neutral rating	Apr. 25	ZD
REDCARE PHARMACY : Jefferies maintains a Buy rating	Apr. 25	ZD
Redcare Pharmacy NV Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Transcript : Redcare Pharmacy NV, Q1 2024 Earnings Call, Apr 25, 2024	Apr. 24
REDCARE PHARMACY : Receives a Buy rating from Baader Bank	Apr. 24	ZD
Swiss online drug delivery firm DocMorris reports slight miss in Q1 sales	Apr. 16	RE
REDCARE PHARMACY : Gets a Buy rating from Jefferies	Apr. 12	ZD
REDCARE PHARMACY : Warburg Research remains Neutral	Apr. 05	ZD
REDCARE PHARMACY : Deutsche Bank maintains a Buy rating	Apr. 05	ZD
REDCARE PHARMACY : Warburg Research gives a Neutral rating	Apr. 04	ZD
REDCARE PHARMACY : Baader Bank maintains a Buy rating	Apr. 04	ZD
REDCARE PHARMACY : Hauck & Aufhauser keeps its Buy rating	Apr. 04	ZD
REDCARE PHARMACY : Jefferies reaffirms its Buy rating	Apr. 04	ZD
REDCARE PHARMACY : Deutsche Bank reiterates its Buy rating	Mar. 22	ZD
REDCARE PHARMACY : Buy rating from Hauck & Aufhauser	Mar. 15	ZD
REDCARE PHARMACY : Warburg Research reaffirms its Neutral rating	Mar. 15	ZD
REDCARE PHARMACY : Jefferies reaffirms its Buy rating	Mar. 14	ZD
REDCARE PHARMACY : Hauck & Aufhauser reiterates its Buy rating	Mar. 12	ZD
REDCARE PHARMACY : Berenberg maintains a Buy rating	Mar. 12	ZD
REDCARE PHARMACY : Deutsche Bank reiterates its Buy rating	Mar. 11	ZD
REDCARE PHARMACY : Deutsche Bank reaffirms its Buy rating	Mar. 06	ZD
REDCARE PHARMACY : Hauck & Aufhauser reiterates its Buy rating	Mar. 06	ZD

Redcare Pharmacy NV is a company based in the Netherlands that retails pharmaceutical products online. The Company focuses on non-prescription medication (OTC), as well as on pharmacy-related beauty and personal care (BPC) products. The Company is active in Belgium, Spain, Italy, France, Austria, the Netherlands and Germany.

Sector

Drug Retailers

Calendar

2024-07-29 - Q2 2024 Earnings Release

Related indices

MDAX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

Shop Apotheke Europe N.V. : Growth still not profitable

March 09, 2023 at 11:32 am EST

More Strategies

Ratings for Redcare Pharmacy NV

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

131.3 EUR

Average target price

155.2 EUR

Spread / Average Target

+18.19%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Drug Retailers

	1st Jan change	Capi.
REDCARE PHARMACY NV	+1.52%	2.86B
WALGREENS BOOTS ALLIANCE, INC.	-33.51%	14.89B
JD HEALTH INTERNATIONAL INC.	-25.06%	12.2B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-28.07%	6.54B
YIFENG PHARMACY CHAIN CO., LTD.	+13.39%	6.37B
MATSUKIYOCOCOKARA & CO.	-9.19%	6.03B
NAHDI MEDICAL COMPANY	-0.44%	4.73B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+59.80%	4.57B
CLICKS GROUP LIMITED	-9.15%	3.82B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-10.72%	3.51B

Other Drug Retailers

Redcare Pharmacy NV

Equities

RDC

NL0012044747

Drug Retailers

REDCARE PHARMACY : Warburg Research reaffirms its Neutral rating

Latest news about Redcare Pharmacy NV

Chart Redcare Pharmacy NV

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Redcare Pharmacy NV

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Other Drug Retailers